Showing results (141-150 of 187) with videos related to
Sort By:
Pageof 19
Annals of Neurology|March 1, 1987
Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methodsC G Goetz, C M Tanner, R S Wilson, et al.Neurology|March 13, 2002
Parkin mutations in a patient with hemiparkinsonism-hemiatrophy: a clinical-genetic and PET studyP P Pramstaller, G Künig, K Leenders, et al.Archives of Internal Medicine|October 1, 1988
Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patientsS M Sprague, H L Corwin, C M Tanner, et al.Neurology|July 1, 1992
Blinded evaluation confirms long-term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's diseaseN Diederich, C G Goetz, G T Stebbins, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2000
Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeysS Palfi, L Leventhal, C G Goetz, et al.Neurology|January 28, 1999
Animal model of posthypoxic myoclonus: effects of serotonergic antagonistsE J Pappert, C G Goetz, T Q Vu, et al.Neurology|September 1, 1993
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuationsM C Kurth, J W Tetrud, C M Tanner, et al.Neurology|July 1, 1988
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuationsC G Goetz, C M Tanner, K M Shannon, et al.Journal of the American Academy of Child and Adolescent Psychiatry|March 14, 2000
Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot studyF R Sallee, R Kurlan, C G Goetz, et al.Neurology|May 1, 1991
The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's diseaseP M Carvey, A McRae, T F Lint, et al.Pageof 19